Showing results (221-230 of 324) with videos related to

Sort By:
Pageof 33
Biochemical Pharmacology|October 23, 1998
Reduction of the indoloquinone anticancer drug EO9 by purified DT-diaphorase: a detailed kinetic study and analysis of metabolitesS M Bailey, A D Lewis, R J Knox, et al.
British Journal of Cancer|January 1, 1993
2'-Chlorodeoxyadenosine: evaluation of a novel predominantly lymphocyte selective agent in lymphoid malignanciesT Hickish, P Serafinowski, D Cunningham, et al.
Molecular Cancer Therapeutics|December 7, 2002
Inhibition of Kirsten-ras expression in human colorectal cancer using rationally selected Kirsten-ras antisense oligonucleotidesP J Ross, M George, D Cunningham, et al.
Analytical Biochemistry|October 25, 2001
High-throughput screening for identification of small molecule inhibitors of histone acetyltransferases using scintillating microplates (FlashPlate)F Turlais, A Hardcastle, M Rowlands, et al.
Biochemical Pharmacology|July 13, 2001
Involvement of NADPH: cytochrome P450 reductase in the activation of indoloquinone EO9 to free radical and DNA damaging speciesS M Bailey, A D Lewis, L H Patterson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2012
Defining the risk of toxicity in phase I oncology trials of novel molecularly targeted agents: a single centre experienceL R Molife, S Alam, D Olmos, et al.
Anti-Cancer Drugs|June 1, 1994
Cyclopropamitosenes: novel bioreductive anticancer agents--mechanism of action and enzymic reductionC J Moody, N O'Sullivan, I J Stratford, et al.
British Journal of Cancer|September 16, 2010
A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinomaJ M G Larkin, T R Ferguson, L M Pickering, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 12, 2017
Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I UnitR Sundar, A Custodio, A Petruckevich, et al.
British Journal of Cancer|August 22, 2013
Rationale and design of a UK database for a rare cancer type: the GEM Registry for gastrointestinal stromal tumoursV R Bulusu, J Fullarton, M Leahy, et al.
Pageof 33